Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 33 contracts
Sources: Exclusive Patent License Agreement (Sigilon Therapeutics, Inc.), Exclusive Patent License Agreement (Sigilon Therapeutics, Inc.), Exclusive Patent License Agreement
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇mark, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇mark, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 6 contracts
Sources: Exclusive Patent License Agreement (SQZ Biotechnologies Co), Exclusive Patent License Agreement (Synlogic, Inc.), Exclusive Patent License and Tangible Property Agreement (Verastem, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and shall use commercially reasonable efforts to cause its SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 5 contracts
Sources: Patent License Agreement (Omega Therapeutics, Inc.), Patent License Agreement (Omega Therapeutics, Inc.), License Agreement
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practicesrequired by applicable patent laws, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES to ▇▇▇▇ and shall use commercially reasonable efforts to cause its SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 4 contracts
Sources: Exclusive Patent License Agreement, Exclusive Patent License Agreement (Rubius Therapeutics, Inc.), Exclusive Patent License Agreement (Rubius Therapeutics, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇m▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇m▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 4 contracts
Sources: Exclusive Patent License Agreement (Bionik Laboratories Corp.), Exclusive Patent License Agreement (Enumeral Biomedical Holdings, Inc.), Exclusive Patent License Agreement (Enumeral Biomedical Holdings, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall mark, ▇▇▇▇, and d shall cause its AFFILIATES and SUBLICENSEES to mark, ▇▇▇▇, all l LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 3 contracts
Sources: Exclusive Patent License Agreement (Intuitive Surgical Inc), Exclusive Patent License Agreement (GMP Companies Inc), Exclusive Patent License Agreement (Lithium Technology Corp)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY Company shall mark, ▇▇▇▇, and d shall cause its AFFILIATES Affiliates and SUBLICENSEES Sublicensees to mark, ▇▇▇▇, all LICENSED PRODUCTS l Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS Patent Rights that applies to such LICENSED PRODUCTLicensed Product.
Appears in 3 contracts
Sources: License Agreement (Signal Pharmaceuticals Inc), License Agreement (Signal Pharmaceuticals Inc), License Agreement (Signal Pharmaceuticals Inc)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 3 contracts
Sources: Non Exclusive Patent License Agreement, Nonexclusive Patent License Agreement (IIOT-OXYS, Inc.), Nonexclusive Patent License Agreement
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement the AGREEMENT with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Elicio Therapeutics, Inc.)
Marking of Licensed Products. To the extent commercially feasible feasible, required by applicable law and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Sources: Tangible Property and Exclusive Patent License Agreement (Proteostasis Therapeutics, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇m▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇m▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the the. PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (BioTrove, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices[***], COMPANY shall ▇▇▇▇mark, and shall cause its AFFILIATES and shall use commercially reasonable efforts to cause its SUBLICENSEES to ▇▇▇▇mark, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the the. PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (BioTrove, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practicesrequired by applicable patent laws, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Verastem, Inc.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇mark, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇mark, all LICENSED PRODUCTS that are manufactured or sold under this Agreement the AGREEMENT with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Angion Biomedica Corp.)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT, contingent upon an approval of any labeling by the FDA within a reasonable timeframe.
Appears in 1 contract
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold SOLD under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Cardiomems Inc)
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇▇▇, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the the. PATENT RIGHTS that applies to such LICENSED PRODUCT. 12.
Appears in 1 contract
Sources: Exclusive Patent License Agreement
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇ma▇▇, and shall cause its AFFILIATES and SUBLICENSEES to ▇▇ma▇▇, all LICENSED PRODUCTS and POLYPEPTIDES that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCTPRODUCT and POLYPEPTIDE.
Appears in 1 contract
Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, COMPANY shall ▇▇▇▇mark, and shall cause its AFFILIATES and SUBLICENSEES to mark, all L▇▇▇▇, all LICENSED SED PRODUCTS that are manufactured or sold under this Agreement ▇▇▇eement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.
Appears in 1 contract